UChicago Researchers Receive $3.5 Million From Nimh to Transform Diagnosis of Psychotic Disorders
University of Chicago Medical CenterSecond phase of the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP2) aims to establish a new system of diagnosis for psychotic diseases based on biomarkers, and guide the development of novel therapies.